Loading clinical trials...
Loading clinical trials...
Dalbavancin For The Treatment Of Gram Positive Osteomyelitis Or Joint Infections Including Prosthetic Hip Or Knee Infections
Conditions
Interventions
Dalbavancin
Vancomycin
Locations
1
United States
Infectious Diseases Physicians, Inc.
Annandale, Virginia, United States
Start Date
January 25, 2018
Primary Completion Date
December 31, 2022
Completion Date
December 31, 2022
Last Updated
October 3, 2023
NCT06827496
NCT03594344
NCT05927311
NCT02979951
NCT05607888
NCT05753215
Lead Sponsor
Infectious Diseases Physicians, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions